SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-262060
Filing Date
2021-08-31
Accepted
2021-08-31 16:10:05
Documents
84
Period of Report
2021-08-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.06: Change in Shell Company Status
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d214779d8k.htm   iXBRL 8-K 360810
2 EX-3.1 d214779dex31.htm EX-3.1 37582
3 EX-3.2 d214779dex32.htm EX-3.2 191349
4 EX-10.3 d214779dex103.htm EX-10.3 170491
5 EX-10.10 d214779dex1010.htm EX-10.10 101886
6 EX-10.11 d214779dex1011.htm EX-10.11 73787
7 EX-10.17 d214779dex1017.htm EX-10.17 93227
8 EX-10.18 d214779dex1018.htm EX-10.18 16827
9 EX-16.1 d214779dex161.htm EX-16.1 2239
10 EX-99.1 d214779dex991.htm   iXBRL EX-99.1 835672
11 EX-99.2 d214779dex992.htm EX-99.2 144754
12 EX-99.3 d214779dex993.htm EX-99.3 238200
13 EX-99.4 d214779dex994.htm EX-99.4 11354
  Complete submission text file 0001193125-21-262060.txt   7607471

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA lwac-20210630.xsd EX-101.SCH 65304
15 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lwac-20210630_cal.xml EX-101.CAL 42778
16 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lwac-20210630_def.xml EX-101.DEF 284092
17 XBRL TAXONOMY EXTENSION LABEL LINKBASE lwac-20210630_lab.xml EX-101.LAB 460915
18 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lwac-20210630_pre.xml EX-101.PRE 371773
19 EXTRACTED XBRL INSTANCE DOCUMENT d214779d8k_htm.xml XML 1043019
Mailing Address 200 CLARENDON STREET, 51ST FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 51ST FLOOR BOSTON MA 02116 2157319450
eFFECTOR Therapeutics, Inc. (Filer) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39866 | Film No.: 211227112
SIC: 2834 Pharmaceutical Preparations